<DOC>
	<DOCNO>NCT02778802</DOCNO>
	<brief_summary>This study design prospective study , primary endpoint change pulmonary hemodynamic parameter ELVR patient severe emphysema . Secondary endpoint change lung function parameter , exercise capacity , QoL .</brief_summary>
	<brief_title>Pulmonary Hemodynamics Patients With Severe Emphysema Pre Post BLVR</brief_title>
	<detailed_description>Chronic obstructive pulmonary disease ( COPD ) continue lead cause morbidity currently third common cause mortality worldwide ( 1 ) . In patient severe COPD , chronic airflow limitation , lung emphysema parenchymal destruction development air bulla also occur ( 2-3 ) Pulmonary hypertension ( PH ) common consequence COPD , although actual overall prevalence PH COPD remain unclear ( 4 ) . Among COPD patient undergo lung-volume-reduction surgery lung transplantation , mild PH observe 50.2 % , moderate PH 9.8 % , severe PH 3.7 % ( 5 ) . While COPD patient develop PH , pulmonary arterial pressure mildly moderately elevate , ( 6 ) PH independent prognostic impact survival . ( 6,7 ) The therapeutic option COPD patient severe emphysema limited . Lung volume reduction surgery ( LVRS ) perform treatment select case , referral patient severely influence marked perioperative morbidity mortality [ 8 ] . Less invasive technique develop aim improve patient ' pulmonary function , symptom , quality life ( QoL ) [ 9 ] . Among , one commonly use endoscopic placement one way endobronchial valve ( EBV ) [ 10-12 ] . So far patient severe emphysema establish PH exclude LVRS well endoscopic lung volume reduction ( ELVR ) therapy . Whether bronchoscopic lung volume reduction COPD patient silver nitrate histoacryl influence severity PH patient severe emphysema PH yet elucidate . This study design prospective pilot study , primary endpoint change pulmonary hemodynamic parameter ELVR patient severe emphysema . Secondary endpoint change lung function parameter , exercise capacity , QoL . Materials Methods This Prospective descriptive study 20 COPD Patients predominant emphysema especially heterogeneous upper lobe predominance emphysema admit chest department Kasr al Ainy Hospital . All patient optimal medical treatment COPD accord Global Initiative Chronic Obstructive Lung Disease guideline [ 13 ] All patient subject follow base line . 1. full history take . 2. full clinical examination . 3. plain chest x ray . 4. electrocardiogram , High resolution compute tomography chest . 5 . Pulmonary function test ABG . 6 . 6-minute walk test . 7 . 2-D echocardiography rest 8 . Right heart catheterization ( RHC ) 9 . Fiberoptic bronchoscopy application silver nitrate histoacryl . The patient follow every month 1 . Dyspnea score ( use mMRC score ) 2 . 6-minute walk test . 3 . ECG At 3rd Month 2-D echocardiography rest do At 6th Month 2-D echocardiography rest And RHC do .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Emphysema</mesh_term>
	<mesh_term>Pulmonary Emphysema</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<criteria>COPD patient predominant emphysema especially heterogeneous upper lobe predominance emphysema 1 . Airflow limitation FEV1 &lt; 20 % . 2 . Patients candidate FOB .</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Pulmonary Hypertension</keyword>
	<keyword>Emphysema</keyword>
	<keyword>COPD</keyword>
</DOC>